Patient Income Level and Cancer Clinical Trial Participation

著者: Joseph M. Unger, Julie R. Gralow, Kathy S. Albain, Scott D. Ramsey, Dawn L. Hershman - JAMA Oncology 2015 被引用: 203

ing to follow-up biopsies. Outcomes measured include changes in clinical management and incidence of false-positive findings defined as biopsy-evaluated PET/CT findings nondiagnostic for melanoma. Fisher exact tests were used to compare clinical factors with PET/CT use.